|
⚲
|
| Keyboard |
| Schuling Douglas A
✚
|
|
|---|---|
| CIK # | 0001414837 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001414837] | |
| 4 | [0001414837] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Miragen Therapeutics Inc | |
| Schuling Douglas A |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Miragen Therapeutics Inc SGNL
Stock Option (Right to Buy) · derivative
|
2016-06-15 | Grant | 18,000 | $0.00 | |
|
Miragen Therapeutics Inc SGNL
Common Stock
|
2015-08-06 | Option exercise | 4,125 | ||
|
Miragen Therapeutics Inc SGNL
Stock Option (Right to Buy) · derivative
|
2015-08-06 | Grant | 18,000 | $0.00 | |
|
Miragen Therapeutics Inc SGNL
Restricted Stock Units · derivative
|
2015-08-06 | Option exercise | 4,125 | $0.00 | |
|
Miragen Therapeutics Inc SGNL
Common Stock
|
2015-08-06 | Grant | 5,000 | $0.00 | |
|
Miragen Therapeutics Inc SGNL
Common Stock
|
2015-07-17 | Option exercise | 1,375 | ||
|
Miragen Therapeutics Inc SGNL
Restricted Stock Units · derivative
|
2015-07-17 | Option exercise | 1,375 | $0.00 | |
|
Miragen Therapeutics Inc SGNL
Restricted Stock Units · derivative
|
2014-07-17 | Grant | 5,500 | $0.00 | |
|
Miragen Therapeutics Inc SGNL
Stock Option (right to buy) · derivative
|
2014-07-17 | Grant | 6,000 | $0.00 |